Affluent Medical [AFME] vs Theraclion S.A [ALTHE] Detailed Stock Comparison

Affluent Medical

Euronext

Theraclion S.A

Euronext

TLDR: Quick Comparison Summary

Based on 17 vital metrics comparison: Affluent Medical wins in 9 metrics, Theraclion S.A wins in 6 metrics, with 0 ties. Affluent Medical appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Affluent Medical	Theraclion S.A	Better
P/E Ratio (TTM)	-4.30	-5.58	Theraclion S.A
Price-to-Book Ratio	1.95	N/A	N/A
Debt-to-Equity Ratio	0.54	-66,510.16	Theraclion S.A
PEG Ratio	N/A	6.58	N/A
EV/EBITDA	-6.14	-5.08	Affluent Medical
Profit Margin (TTM)	-275.50%	-346.01%	Affluent Medical
Operating Margin (TTM)	-124.14%	-294.95%	Affluent Medical
Return on Equity	-48.69%	-203.90%	Affluent Medical
Return on Assets (TTM)	-24.22%	-28.29%	Affluent Medical
Free Cash Flow (TTM)	$-11.47M	$-3.01M	Theraclion S.A
1-Year Return	-15.38%	136.67%	Theraclion S.A
Price-to-Sales Ratio (TTM)	11.22	37.82	Affluent Medical
Enterprise Value	$75.10M	$33.02M	Affluent Medical
EV/Revenue Ratio	18.24	39.77	Affluent Medical
Revenue per Share (TTM)	$0	$0	Affluent Medical
Earnings per Share (Diluted)	$-0.41	$-0.10	Theraclion S.A
Beta (Stock Volatility)	0.62	-0.15	Theraclion S.A

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Affluent Medical vs Theraclion S.A Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Affluent Medical	-3.02%	14.58%	32.00%	18.71%	23.13%	18.71%
Theraclion S.A	-2.27%	9.23%	86.84%	153.57%	273.68%	97.22%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Affluent Medical	-15.38%	-42.71%	-79.25%	-79.25%	-79.25%	-79.25%
Theraclion S.A	136.67%	-36.61%	-44.09%	-90.48%	-94.34%	-94.34%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Affluent Medical (AFME): View Full Stock Overview

Theraclion S.A (ALTHE): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Affluent Medical vs Theraclion S.A

Metric	AFME	ALTHE
Market Information
Market Cap i	€60.00M	€31.40M
Market Cap Category	Small cap	Small cap
10 Day Avg. Volume i	18,838	164,174
90 Day Avg. Volume i	10,711	152,601
Last Close	€1.61	€0.69
52 Week Range	€1.16 - €1.99	€0.14 - €0.80
% from 52W High	-19.35%	-13.32%
All-Time High	€8.60 (Jun 14, 2021)	€13.35 (May 05, 2014)
% from All-Time High	-81.28%	-94.83%
Growth Metrics
Quarterly Revenue Growth	6.40%	0.27%
Quarterly Earnings Growth	N/A	N/A
Financial Health
Profit Margin (TTM) i	-2.76%	-3.46%
Operating Margin (TTM) i	-1.24%	-2.95%
Return on Equity (TTM) i	-0.49%	-2.04%
Debt to Equity (MRQ) i	0.54	-66,510.16
Cash & Liquidity
Book Value per Share (MRQ)	€0.79	€0.00
Cash per Share (MRQ)	N/A	€0.09
Operating Cash Flow (TTM) i	€-11,324,000	€-2,911,000
Levered Free Cash Flow (TTM) i	€-14,739,000	€-242,576
Dividends
Last 12-Month Dividend Yield i	N/A	N/A
Last 12-Month Dividend i	N/A	N/A

Valuation & Enterprise Metrics Analysis: Affluent Medical vs Theraclion S.A

Metric	AFME	ALTHE
Price Ratios
P/E Ratio (TTM) i	-4.30	-5.58
Forward P/E i	-1.52	6.58
PEG Ratio i	N/A	6.58
Price to Sales (TTM) i	11.22	37.82
Price to Book (MRQ) i	1.95	N/A
Market Capitalization
Market Capitalization i	€60.00M	€31.40M
Enterprise Value i	€75.10M	€33.02M
Enterprise Value Metrics
Enterprise to Revenue i	18.24	39.77
Enterprise to EBITDA i	-6.14	-5.08
Risk & Other Metrics
Beta i	0.62	-0.15
Book Value per Share (MRQ) i	€0.79	€0.00

Financial Statements Comparison: Affluent Medical vs Theraclion S.A

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	AFME	ALTHE
Revenue/Sales i	N/A	N/A
Cost of Goods Sold i	N/A	N/A
Gross Profit i	N/A	N/A
Research & Development i	N/A	N/A
Operating Income (EBIT) i	N/A	N/A
EBITDA i	N/A	N/A
Pre-Tax Income i	N/A	N/A
Income Tax i	N/A	N/A
Net Income (Profit) i	N/A	N/A

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	AFME	ALTHE
Cash & Equivalents i	€1.23M	€4.17M
Total Current Assets i	€12.16M	€8.27M
Total Current Liabilities i	€9.53M	€3.75M
Long-Term Debt i	€14.59M	€1.30M
Total Shareholders Equity i	€30.27M	€-114
Retained Earnings i	€-70.85M	€-5.76M
Property, Plant & Equipment i	€235,000	€1.66M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	AFME	ALTHE
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	AFME	ALTHE
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	18,838	164,174
Average Daily Volume (90 Day) i	10,711	152,601
Shares Outstanding i	39.17M	46.01M
Float Shares i	N/A	24.44M
% Held by Insiders i	0.22%	0.62%
% Held by Institutions i	0.60%	0.01%

Dividend Analysis & Yield Comparison: Affluent Medical vs Theraclion S.A

Metric	AFME	ALTHE
Last 12-Month Dividend i	N/A	N/A
Last 12-Month Dividend Yield i	N/A	N/A
3-Year Avg Annual Dividend i	N/A	N/A
3-Year Avg Dividend Yield i	N/A	N/A
3-Year Total Dividends i	N/A	N/A
Ex-Dividend Date	N/A	N/A

Affluent Medical [AFME] vs Theraclion S.A [ALTHE] Detailed Stock Comparison